Graves disease
Graves disease
Updated: 12/13/2018
© Jun Wang, MD, PhD
General features
- Autoimmune disorder
- Most common cause of hyperthyroidism
- Peak incidence between 20 and 40
- More common in women
- Risk for life threatening thyrotoxicosis if untreated
Pathogenesis
- Autoantibody against multiple thyroid proteins, most importantly the TSH receptor
- Autoantibody activate TSH receptor to promote thyroid hyperplasia and hyperfunction
Clinical presentations
- Hyperthyroidism associated with diffuse enlargement of the gland
- Infiltrative ophthalmopathy with resultant exophthalmos
- Localized, infiltrative dermopathy, sometimes called pretibial myxedema, which is present in a minority of patients
Infiltrative ophthalmopathy
- Proptosis in addition to other ocular presentations of hyperthyroidism
- Activated T-cells cross react with TSH receptor expressed in fibroblasts, causing cytokine production and subsequent edema and fibrosis
- Increased volume of the extraocular muscles and retro-orbital connective tissues
- Marked infiltration of the retro-orbital space by mononuclear cells, predominantly T cells
- Inflammation with edema and swelling of extraocular muscles
Key laboratory findings
- Low TSH, usually first positive finding
- High thyroxin or FTI
- Increased uptake of radioactive iodine
- Positive activating autoantibodies against TSH receptor
- Other autoantibodies: Thyroglobulin, thyroid peroxidase, and sodium-iodide symporter
Genetic abnormalities
- CTLA4, etc
Pathological features
- Diffuse hyperplasia and hypertrophy of follicular cells
- Intact follicles
- Tall follicular cells with papillae without fibrovascular cores
- Pale colloid with scalloped margins
Treatment
- Beta-blockers
- Inhibitors for thyroid hormone synthesis (propylthiouracil, etc)
- Radioiodine ablation
- Surgery
Back to pathology of endocrine system
Back to contents
Comments
Post a Comment